Overview of Dr. Leon
Dr. Martin Leon is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Lawrence Hospital. He received his medical degree from Yale School of Medicine and has been in practice 47 years. He is one of 325 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 694 doctors at New York-Presbyterian Hospital who specialize in Cardiology. He has more than 100 publications and over 500 citings.
Office
161 Fort Washington Avenue
New York, NY 10032
Education & Training
- Yale-New Haven Medical CenterFellowship, Cardiovascular Disease, 1980 - 1982
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1975 - 1978
- Yale School of MedicineClass of 1975
Certifications & Licensure
- CA State Medical License 1982 - Present
- NY State Medical License 1999 - 2026
- MD State Medical License 1979 - 2002
- DC State Medical License 1989 - 2000
- PA State Medical License 1994 - 2000
- CT State Medical License 1977 - 1982
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Mitral regurgitation evolution after transcatheter tricuspid valve interventions-a sub-analysis of the TriValve registry.Francesco Cannata, Alessandro Sticchi, Giulio Russo, Kamil Stankowski, Rebecca T Hahn
European Heart Journal. Cardiovascular Imaging. 2024-12-31 - Novel cardiac CT method for identifying the atrioventricular conduction axis by anatomic landmarks.Justin T Tretter, Francisco Bedogni, Josep Rodés-Cabau, Ander Regueiro, Luca Testa
Heart Rhythm. 2024-12-18 - Five Year Outcomes in Low-Risk Patients Undergoing Surgery in the PARTNER 3 Trial.Vinod H Thourani, Martin B Leon, Raj Makkar, Guido Ascione, Wilson Y Szeto
The Annals of Thoracic Surgery. 2024-12-16
Press Mentions
- From Intervention to Prevention: The Latest Innovations and Expertise from TCT 2024November 15th, 2024
- FDA Clears New Device for Valve-in-Valve TAVR Patients at Risk of Coronary ObstructionSeptember 30th, 2024
- Pi-Cardia Receives FDA Market Clearance for ShortCut Dedicated Leaflet Modification Device to Enable TAVR in Patients at Risk of Coronary ObstructionSeptember 30th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: